Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.
Neurotherapy Rehabilitation Center, São Paulo, SP, Brazil.
Eur J Neurol. 2021 Feb;28(2):609-619. doi: 10.1111/ene.14587. Epub 2020 Nov 12.
Spinal muscular atrophy (SMA) is the most important cause of motor neuron disease in childhood, and continues to represent the leading genetic cause of infant death. Adulthood-onset SMA (SMA type 4) is rare, with few isolated cases reported. The objective of the present study was to describe a cohort of patients with SMA type 4.
A cross-sectional study was conducted to characterize clinical, genetic, radiological and neurophysiological features of patients with adulthood-onset SMA. Correlation analysis of functional assessment with genetic, radiological and neurophysiological data was performed.
Twenty patients with SMA type 4 were identified in a Brazilian cohort of 227 patients with SMA. The most common clinical symptom was limb-girdle muscle weakness, observed in 15 patients (75%). The most frequent neurological findings were absent tendon reflexes in 18 (90%) and fasciculations in nine patients (45%). Sixteen patients (80%) had the homozygous deletion of exon 7 in the SMN1 gene, with 12 patients (60%) showing four copies of the SMN2 gene. The functional scales Hammersmith Functional Motor Scale Expanded, Amyotrophic Lateral Sclerosis Functional Rating Scale Revised, Revised Upper Limb Module and Spinal Muscular Atrophy Functional Rating Scale, as well as the six-minute walk and the Time Up and Go tests showed a correlation with duration of disease. Motor Unit Number Index was correlated both with duration of disease and with performance in functional assessment. Radiological studies exhibited a typical pattern, with involvement of biceps femoris short head and gluteus minimus in all patients.
This study represents the largest cohort of patients with SMA type 4 and provides functional, genetic, radiological and neurophysiological features that can be used as potential biomarkers for the new specific genetic therapies for SMA.
脊髓性肌萎缩症(SMA)是儿童运动神经元病的最重要原因,仍然是婴儿死亡的主要遗传原因。成人发病型 SMA(SMA 型 4)较为罕见,仅有少数孤立病例报道。本研究旨在描述一组 SMA 型 4 患者。
进行了一项横断面研究,以描述成人发病型 SMA 患者的临床、遗传、影像学和神经生理学特征。对功能评估与遗传、影像学和神经生理学数据进行相关性分析。
在巴西 SMA 患者 227 例的队列中发现了 20 例 SMA 型 4 患者。最常见的临床症状是肢体带肌无力,15 例患者(75%)出现该症状。最常见的神经学发现是 18 例(90%)无腱反射和 9 例(45%)肌束颤动。16 例患者(80%)SMN1 基因外显子 7 纯合缺失,12 例患者(60%)有 4 个 SMN2 基因拷贝。功能量表包括 Hammersmith 功能运动量表扩展版、肌萎缩侧索硬化功能评定量表修订版、修订后的上肢模块和脊髓性肌萎缩功能评定量表,以及 6 分钟步行和起立-行走计时测试,与疾病持续时间呈相关性。运动单位数量指数与疾病持续时间和功能评估表现均呈相关性。影像学研究显示出典型的模式,所有患者均累及肱二头肌短头和臀小肌。
本研究是 SMA 型 4 患者最大的队列研究,提供了功能、遗传、影像学和神经生理学特征,可作为 SMA 新型特定基因治疗的潜在生物标志物。